Latest News

• share
• favorite_border

The Foundation for Women’s Cancer (FWC) recognizes September as Gynecologic Cancer Awareness Month annually, and this year is sharing an array of impactful resources aimed at raising awareness about gynecologic cancers and promoting education. FWC provides free educational materials and informative trainings and webinars year-round, and this month will be featuring new and existing resources for those at risk to develop gyn cancer, as well as gyn cancer patients, caregivers, survivors, and health care professionals.

• share
• favorite_border

The 2023 SGO Annual Meeting on Women's Cancer will be held Saturday, March 25 through Tuesday, March 28 at the Tampa Convention Center in Tampa, Florida. Meeting registration, presenters, session titles and details, press details, and more can be found at sgo.org/annual-meeting.

• share
• favorite_border

While the popular high-fat, zero-carb ketogenic diet or “keto” diet has been thought to help treat cancer, results from a new animal study suggest the opposite: in mice with ovarian cancer, the keto diet significantly increased tumor growth and altered the composition of the gut microbiome.

• share
• favorite_border

Racial disparities have profound effects on gynecologic cancer patients and their cancer outcomes in terms of both race-based stress that contributes to interruptions in care and social needs that are more prevalent and urgent among non-White patients.

• share
• favorite_border

The Society of Gynecologic Oncology (SGO) today recognized excellence in gynecologic cancer research and treatment with the presentation of several awards during the Society’s 2022 Annual Meeting on Women’s Cancer in Phoenix, March 18 – 21.

• share
• favorite_border

The Foundation for Women’s Cancer (FWC) is pleased to announce the winners of its 2021-22 FWC Research Grants and Awards. This year the FWC awarded a total of 16 awards: fourteen research grants – two being Diversity Inclusion & Health Equity Grants, and two prizes in the amount of nearly $728,500.

• share
• favorite_border

The Society of Gynecologic Oncology announced its 2022-2023 Board of Directors during its business meeting on Saturday, March 19.

• share
• favorite_border

Minimally invasive surgery was associated with lower survival rates than open surgery as a treatment for cervical cancer, according to the final analysis of data from the LACC trial.

• share
• favorite_border

Artificial intelligence (AI) can predict treatment outcomes in ovarian cancer at the time of pre-surgical assessment with a high degree of accuracy, according to results of a new pilot study.

• share
• favorite_border

Gynecologic oncology patients who are diagnosed with COVID-19 have a high risk of cancer treatment delays, hospitalization, and death, with non-White race further increasing adverse outcomes, according to the results of a new study.

• share
• favorite_border

The Society of Gynecologic Oncology (SGO) convened experts from the American College of Obstetricians and Gynecologists (ACOG), National Society of Genetic Counselors, Bright Pink and Facing Our Risk of Cancer Empowered (FORCE), to develop the SGO Genetics Toolkit.

• share
• favorite_border

The American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) jointly issued new clinical practice guidelines for the treatment of patients with ovarian cancer.1

• share
• favorite_border

effrey Fowler, MD, John G. Boutselis Chair in Gynecologic Oncology and Professor and vice-chair of Obstetrics and Gynecology at The Ohio State University Wexner Medical Center in Columbus, started his one-year term as the 48th President of the Society of Gynecologic Oncology (SGO) today at the conclusion of the Society’s 47th Annual Meeting on Women’s Cancer in San Diego.

• share
• favorite_border

The Claudia Cohen Research Foundation and the Foundation for Women’s Cancer announced today that Michael J. Birrer, MD, PhD, has been selected as the 2016 recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher.

• share
• favorite_border

The Society of Gynecologic Oncology has appointed Pierre M. Désy, MPH, CAE, as Chief Executive Officer of the Society and its Foundation for Women’s Cancer, effective April 25, 2016.

• share
• favorite_border

Gynecologic oncology research, education and awareness took a historic step forward on Jan. 1, 2016, when the Society of Gynecologic Oncology’s Foundation for Gynecology Oncology and the Foundation for Women’s Cancer (FWC) became one foundation within the SGO.

• share
• favorite_border

Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, has started his one-year term as the 47th President of the Society of Gynecologic Oncology (SGO) and fifth President of the Foundation for Gynecologic Oncology.

• share
• favorite_border

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the cancer’s return.

• share
• favorite_border

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing.

• share
• favorite_border

The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).

• share
• favorite_border

The Society of Gynecologic Oncology (SGO) welcomes new options for detecting and preventing cervical cancer, including the primary human papillomavirus (HPV) testing recently approved by the FDA.

• share
• favorite_border

Veliparib, an oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.

• share
• favorite_border

Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings.

• share
• favorite_border

Women with ovarian and other gynecologic cancers live significantly longer when they receive care at hospitals that treat a large number of patients with these conditions, according to research on more than 850,000 women.

• share
• favorite_border

Women who had bariatric surgery to lose weight had a 70 percent lower risk of uterine cancer and an even lower risk if they kept the weight off, according to findings of a study based on more than 7 million hospital admissions.

• share
• favorite_border

Richard R. Barakat, MD, FACS, will begin his one-year term as the 46th President of the Society of Gynecologic Oncology (SGO) and fourth President of the Foundation for Gynecologic Oncology at the conclusion of the Society’s 45th Annual Meeting.

• share
• favorite_border

The Society of Gynecologic Oncology (SGO) will recognize excellence in gynecologic cancer research and treatment with the presentation of several awards during the Society’s 45th Annual Meeting on Women’s Cancer in Tampa, March 22 – 25, 2014.

• share
• favorite_border

The Society of Gynecologic Oncology (SGO) today released a list of specific tests or procedures that are commonly ordered but not always necessary in gynecologic oncology as part of Choosing Wisely®, an initiative of the ABIM Foundation.

• share
• favorite_border

From losing weight to knowing their family history, there are several things women can do to lower their risk of developing certain types of cancer, and improve their chances for survival if they do develop one of them, according to the Society of Gynecologic Oncology (SGO).

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Barbara A. Goff, MD, will begin her term as the 45th President of the Society of Gynecologic Oncology (SGO) and third President of the Foundation for Gynecologic Oncology at the conclusion of the 44th Annual Meeting on Women’s Cancer, March 9-12, 2013, in Los Angeles.

• share
• favorite_border

A recent study suggests that women are 30% less likely to die of ovarian cancer if they have guideline-recommended treatment, yet nearly 2/3 of those with the disease do not receive it, often because they are cared for at hospitals that treat a small number of ovarian cancer patients.

• share
• favorite_border

A recent study suggests that patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy.

• share
• favorite_border

The SGO will recognize excellence in gynecologic cancer research and treatment with the presentation of several awards during the Opening Ceremony at the Annual Meeting on Women’s Cancer in Los Angeles on Saturday, March 9, 2013.

• share
• favorite_border

Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight SGO Annual Meeting on Women’s Cancer March 9-12 in Los Angeles.

• share
• favorite_border

The Society of Gynecologic Oncology (SGO) proposed new ways to deliver high quality, cost-effective care to women with gynecologic cancers in an SGO report, "Creating a New Paradigm in Gynecologic Cancer Care: Policy Proposals for Delivery, Quality and Reimbursement."

• share
• favorite_border

• share
• favorite_border

Due to the psychosexual consequences and significant morbidity associated with the standard radical vulvectomy procedure, there has been a trend toward vulvar conservation in the management of women with vulvar cancer.